The report on Global Contraceptive market forecast 2015-2022 provides detailed overview and predictive analysis of the market.The global contraceptive market is expected to grow well during the forecasted period on the back of factors such as growing prevalence of sexually transmitted infections (STIs), such as HIV. The presence of high unmet contraceptive needs coupled with the implementation of favorable government policies is expected to significantly contribute towards the growth of the contraceptives industry. However various ethical and social issues restrict the use of contraceptives in some countries in Middle-East region. These are some factors restraining the market growth.

The application market for contraceptive is segmented by products and geography. The products segment is further divided into drugs, such as topical contraceptives, injectable, and oral contraceptive pills. Out of all the segments, contraceptive devices holds the largest market share with 62%, presently. Male and female condoms, vaginal implants, subdermal implants, diaphragms, sponges and IUDs are key devices accounted for the significant share of the contraceptives market in terms of revenue. This is because of the increase in the awareness level about sexually transmitted disease (STD) and the efficiency of condoms to prevent the infections, including HIV.

For Detail of Report with Table of contents :

The key players in global contraceptive market include Teva Pharmaceutical Industries, The Female Health Company, Reckitt Benckiser Plc, Pfizer Inc., Church & Dwight, Mayer Laboratories, Cooper Surgical, Actavis plc, and Merck & Co.etc. The market has high level of competition and remains the same during the forecasted period with constant pressure on players to launch new products.

Scope of the Report

1. Global contraceptive market by products 2012 – 2022
1.1. Contraceptive Drugs
1.1.1. Contraceptive Pills
1.1.2. Topical
1.1.3. Injectable
1.2. Contraceptive Devices
1.2.1. Male Condoms
1.2.2. Female Condoms
1.2.3. Vaginal Implants
1.2.4. Subdermal Implants
1.2.5. Diaphragms
1.2.6. Sponges
1.2.7. IUDs
1.3. Copper IUD
1.4. Hormonal IUD

2. Global contraceptiveindustry, regional outlook 2012-2022 ($ BILLION)
2.1. North America
2.2. Europe
2.3. Asia Pacific
2.4. Middle East & Africa
2.5. Central & South America

Detailed study on this Report :

Contact Us :

Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Phone : +448081890034 (UK)

Web :